Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05553834
What this trial is testing

PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Duke University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06576921
What this trial is testing

Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

Who this might be right for
Stomach NeoplasmsImmune Checkpoint Inhibitors
Xijing Hospital 116
Not applicableNot Yet RecruitingNCT07198958
What this trial is testing

Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy

Who this might be right for
CancerCancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)Cancer (Solid Tumors)+1 more
IRCCS San Raffaele 500
Testing effectiveness (Phase 2)UnknownNCT04715633
What this trial is testing

PD-1 Inhibitors Combined With VEGF Inhibitors for Locally Advanced dMMR/MSI-H Colorectal Cancer

Who this might be right for
Colorectal CancerMicrosatellite Instability High
Sun Yat-sen University 53
Testing effectiveness (Phase 2)UnknownNCT05957016
What this trial is testing

Neoadjuvant CIETAI With Concurrent Chemoradiotherapy in Local Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Third Military Medical University 90
Not applicableActive Not RecruitingNCT06762158
What this trial is testing

NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
RenJi Hospital 50
Early research (Phase 1)Looking for participantsNCT05142189
What this trial is testing

Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BioNTech SE 320
Large-scale testing (Phase 3)Active Not RecruitingNCT04949113
What this trial is testing

Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma

Who this might be right for
Malignant Melanoma Stage III
The Netherlands Cancer Institute 423
Large-scale testing (Phase 3)Not Yet RecruitingNCT07132008
What this trial is testing

Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer

Who this might be right for
Colonic NeoplasmsNeoadjuvant TherapyImmune Checkpoint Inhibitors
First Affiliated Hospital of Guangxi Medical University 94
Not applicableUnknownNCT04115410
What this trial is testing

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

Who this might be right for
Carcinoma, Non-Small-Cell LungImmune-Related Adverse Events
Sungkyunkwan University 4,724
Early research (Phase 1)WithdrawnNCT03605589
What this trial is testing

Pembro + Blina Combination in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Leukemia or Lymphoma

Who this might be right for
Leukemia, B-cellLymphoma, B-Cell
Children's Hospital Medical Center, Cincinnati
Testing effectiveness (Phase 2)UnknownNCT05401279
What this trial is testing

Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder Cancer

Who this might be right for
Urothelial Carcinoma BladderPD-1 Inhibitor
RenJi Hospital 20
Testing effectiveness (Phase 2)UnknownNCT05842018
What this trial is testing

Toripalimab in Combination With Chemotherapy and Antiangiogenic Agents in Patients With Non-Small Cell Lung Cancer After Failure of Immunotherapy (PD-1/L1 Inhibitors)

Who this might be right for
Non Small Cell Lung Cancer Recurrent
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableNot Yet RecruitingNCT07533357
What this trial is testing

Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Fudan University 158
Not applicableLooking for participantsNCT05878964
What this trial is testing

Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.

Who this might be right for
Lung CancerBreast CancerKidney Cancer+5 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 420
Testing effectiveness (Phase 2)Active Not RecruitingNCT04836728
What this trial is testing

Phase II Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer MetastaticFirst-line Treatment
Tianjin Medical University Cancer Institute and Hospital 156
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06045195
What this trial is testing

Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Cologne 40
Large-scale testing (Phase 3)UnknownNCT03427827
What this trial is testing

PD-1 Antibody Versus Best Supportive Care After Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 450
Testing effectiveness (Phase 2)Study completedNCT03620019
What this trial is testing

Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma

Who this might be right for
Melanoma Stage IiiMelanoma Stage IvMelanoma+2 more
UNC Lineberger Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07417501
What this trial is testing

Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification

Who this might be right for
Solid Tumors
Tongji Hospital 60
Next Page